Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/1999
02/04/1999WO1999004820A2 Cytolysis of target cells by superantigen conjugates inducing t-cell activation
02/04/1999WO1999004810A2 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment
02/04/1999WO1999004807A1 Recombinant immunotoxin containing a diphterial toxin and interleukin -2(dt482-il2) and method for preparing the same
02/04/1999WO1999004800A1 Nucleic acid compositions and methods of introducing nucleic acids into cells
02/04/1999WO1999004775A2 Method of treating dopaminergic and gaba-nergic disorders
02/04/1999WO1999004626A1 Novel gene encoding a dna repair endonuclease and methods of use thereof
02/04/1999WO1999004622A1 Transgenic plants with tocopherol methyltransferase
02/04/1999WO1999004621A1 A molecular marker for the gene determining the fructose to glucose ratio in mature tomato fruit
02/04/1999WO1999004618A1 A method of producing transformed cells of barley
02/04/1999WO1998051782A3 Human 3-hydroxyisobutyryl-coenzyme a hydrolase
02/04/1999WO1998051695A3 Novel polyketide derivatives and recombinant methods for making same
02/04/1999WO1998050570A3 Methods and compositions for use of (iso)eugenol methyltransferase
02/04/1999WO1998050558A3 Production of ascorbic acid in plants
02/04/1999WO1998050546A3 B cell receptor associated proteins
02/04/1999WO1998050433A3 Human monoclonal antibodies to epidermal growth factor receptor
02/04/1999WO1998050424A3 Human serine protease precursor
02/04/1999WO1998050081A3 In vivo expression system for cellular receptors
02/04/1999WO1998050079A3 Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes
02/04/1999WO1998049287A3 Antisense oligonucleotides specific for thymidylate synthase
02/04/1999DE19733364A1 Verfahren zur Klonierung eines großen Virusgenoms Method for cloning a large viral genome
02/04/1999DE19732926A1 New DNA encoding glucose-6-phosphate translocator from pea, maize or potato
02/04/1999DE19732829A1 Sekretion von trägergebundenen Proteinen in das Periplasma und in den extrazellulären Raum Secretion of carrier-bound proteins in the periplasm and in the extracellular space
02/04/1999DE19732751A1 Neue Beta-Glucanase aus Bacillus New beta-glucanase from Bacillus
02/04/1999CA2732570A1 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment
02/04/1999CA2308146A1 Collagen type i and type iii adhesive compositions
02/04/1999CA2305624A1 Recombinant lysostaphin analogs
02/04/1999CA2300695A1 Novel compositions for the delivery of negatively charged molecules
02/04/1999CA2298980A1 Novel gene encoding a dna repair endonuclease and methods of use thereof
02/04/1999CA2298410A1 Intracellular inhibitors of gq protein signaling
02/04/1999CA2298117A1 Computer method and system for correlating sequencing data by ms
02/04/1999CA2298114A1 Human chloride ion channel zsig44
02/04/1999CA2298107A1 Use of transcription factor brn-3a
02/04/1999CA2298103A1 Non-b, non-c, non-g hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus
02/04/1999CA2298069A1 Method for producing and identifying new hydrolases having improved properties
02/04/1999CA2298067A1 Conjugates of transporter peptides and nucleic acid analogs, and their use
02/04/1999CA2298063A1 Mycobacterium strain with modified erp gene and vaccine composition containing same
02/04/1999CA2298053A1 Novel estrogen receptor .beta. and isoforms
02/04/1999CA2298050A1 Transgenic plants with tocopherol methyltransferase
02/04/1999CA2298017A1 Multiple functionalities within an array element and uses thereof
02/04/1999CA2298015A1 Production of erythropoietin by endogenous gene activation
02/04/1999CA2297907A1 Human estrogen receptor beta
02/04/1999CA2297661A1 Amplification and other enzymatic reactions performed on nucleic acid arrays
02/04/1999CA2297491A1 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
02/04/1999CA2297487A1 Cationic polymers, complexes associating said cationic polymers with therapeutically active substances comprising at least a negative charge, in particular nucleic acids, and their use in gene therapy
02/04/1999CA2297410A1 Method of treating dopaminergic and gaba-nergic disorders
02/04/1999CA2297381A1 Method for producing biotin
02/04/1999CA2297375A1 Ghrh expression system and methods of use
02/04/1999CA2297364A1 Novel nucleic acid molecules and uses therefor
02/04/1999CA2297175A1 Polyethylenimine-based biomolecule arrays
02/04/1999CA2296798A1 Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents
02/04/1999CA2296734A1 High specificity homocysteine assays for biological samples
02/04/1999CA2296292A1 Secreted proteins encoded by human chromosome 13
02/04/1999CA2296051A1 Genes controlling phytate metabolism in plants and uses thereof
02/04/1999CA2266456A1 Method for typing of minor histocompatibility antigen ha-1
02/04/1999CA2265570A1 Method for selecting transformed cells
02/04/1999CA2239267A1 Novel compounds
02/03/1999EP0895082A2 Method of spotting probe on solid support, probe array and method of manufacturing thereof, and method of detecting target substance and method of identifying structure of target substance using probe array
02/03/1999EP0894870A2 Extraction of fungal cells from clinical material
02/03/1999EP0894868A2 Process for producing nucleoside derivatives
02/03/1999EP0894866A1 Promoter
02/03/1999EP0894865A2 Chimeric herbicide resistance gene
02/03/1999EP0894864A1 Genes encoding enzymes of the ACDH-family in plants and methods for producing transgenic seeds or plants with enhanced content or altered compsition of fatty acids and/or amino acids
02/03/1999EP0894863A1 A YAK-1 related serine/threonine protein kinase-HTLAR33
02/03/1999EP0894862A2 Novel CysS
02/03/1999EP0894861A2 Glycogen phosphorylase from Streptococcus pneumoniae
02/03/1999EP0894860A1 Thermostable DNA polymerases and deletion mutants thereof
02/03/1999EP0894859A2 Asparaginyl tRNA synthetase from Streptococcus pneumoniae
02/03/1999EP0894858A2 Prolyl tRNA synthetase from Streptococcus pneumoniae
02/03/1999EP0894857A2 SecA gene from Streptococcus pneumoniae
02/03/1999EP0894856A1 A human sMAD3 splice variant
02/03/1999EP0894855A2 Human I kappa B-beta transcription factor
02/03/1999EP0894854A2 A novel splicing variant of the epstein-barr virus-induced g-protein coupled receptor
02/03/1999EP0894853A1 Transcriptional silencer protein NRF, nucleic acid molecules encoding it and their use
02/03/1999EP0894806A1 Novel pheS
02/03/1999EP0894269A1 Tfiib transcription factor from candida albicans
02/03/1999EP0894147A1 Detection of variations in human h2 receptors
02/03/1999EP0894146A1 Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer methastasis formation
02/03/1999EP0894144A2 Diagnosing trinucleotide repeat diseases and genes involved therein
02/03/1999EP0894141A1 Hybrid proteins which form heterodimers
02/03/1999EP0894140A1 Allele suppression
02/03/1999EP0894139A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy
02/03/1999EP0894138A1 Recombinant process for the production in pseudomonas putida of the cytochrome c 551? of pseudomonas aeruginosa
02/03/1999EP0894137A1 Novel human myeloid terminal differentiation response gene
02/03/1999EP0894136A1 Method of treating muscular disorders
02/03/1999EP0894135A1 Multivalent and multispecific antigen-binding protein
02/03/1999EP0894134A1 Exodus chemokine materials and methods
02/03/1999EP0894133A2 Neuropeptide y receptor y5 and nucleic acid sequence
02/03/1999EP0894132A2 Adam proteins and uses thereof
02/03/1999EP0894131A1 Human hyaluronan receptor
02/03/1999EP0894130A1 Modulators of tnf receptor associated factor (traf), their preparation and use
02/03/1999EP0894129A1 Short external guide sequences
02/03/1999EP0894126A1 Alkaline protease deficient filamentous fungi
02/03/1999EP0894006A1 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE THREONYL tRNA SYNTHETASE FAMILY
02/03/1999EP0894004A1 Methods for enhancing functional recovery following central nervous system ischemia or trauma
02/03/1999EP0869707A4 High-affinity potassium uptake transporter from higher plants
02/03/1999EP0833940A4 Encoded reaction cassette
02/03/1999EP0758841A4 Cotton modification using ovary-tissue transcriptional factors
02/03/1999EP0703789B1 Vaccine containing a serine protease
02/03/1999EP0674713B1 A disease resistance gene from maize as a selectable marker
02/03/1999EP0669897B1 Separation of nucleic acid fragments
1 ... 3437 3438 3439 3440 3441 3442 3443 3444 3445 3446 3447 3448 3449 3450 3451 3452 3453 3454 3455 3456 3457 ... 4023